September 24, 2024 Press release - Non-regulatory Circio selected for oral presentation at ESGCT 2024 annual meeting
August 26, 2024 Press release - Non-regulatory Circio Holding ASA: Invitation to first half-year 2024 presentation on Thursday 29 August at 10:00am CEST
August 12, 2024 Press release - Regulatory Circio Holding ASA – NOK 1.5m requested from Atlas under NOK 10m rights issue commitment
July 26, 2024 Press release - Regulatory Circio Holding ASA – Information about the warrants issued in connection with the rights issue and new share capital registered
July 9, 2024 Press release - Regulatory Circio Holding ASA – Mandatory notification of trade by primary insiders and close associates related to the rights issue
July 8, 2024 Press release - Regulatory Circio Holding ASA – Last day of the subscription period in the rights issue
July 5, 2024 Press release - Regulatory Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders
July 3, 2024 Press release - Regulatory Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders
July 2, 2024 Press release - Regulatory Circio Holding ASA – Last day of trading in subscription rights in the rights issue
June 28, 2024 Press release - Regulatory Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders
June 26, 2024 Press release - Non-regulatory Circio Holding ASA – Link to online subscription in the rights issue
June 26, 2024 Press release - Regulatory Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences
June 25, 2024 Press release - Non-regulatory Circio´s leading position in circular RNA therapeutics highlighted by broad recent coverage in international life science industry media
June 24, 2024 Press release - Regulatory Circio Holding ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates
June 24, 2024 Press release - Regulatory Circio Holding ASA – Commencement for the subscription period for the rights issue
June 19, 2024 Press release - Regulatory Circio Holding ASA – Minutes from the annual general meeting 2024 and approval of Rights Issue
June 18, 2024 Press release - Regulatory Circio Holding ASA – Approval and publication of prospectus for the rights issue
June 18, 2024 Press release - Regulatory Circio Holding ASA – Updated key information relating to the rights issue
June 18, 2024 Press release - Regulatory Circio Holding ASA – Updated information to the notice of annual general meeting 2024
June 17, 2024 Press release - Non-regulatory Circio announces strengthened in vivo data and enhanced circVec 2.2 design, presented by management in R&D webcast
June 6, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversions of convertible bonds and change of the ratio of subscription rights in the Rights Issue
June 6, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
June 4, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
June 3, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
May 30, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
May 29, 2024 Press release - Regulatory Circio Holding ASA – Key information relating to the rights issue
May 29, 2024 Press release - Regulatory Circio announces financing that secures cash runway for twelve months
May 29, 2024 Press release - Regulatory Circio Holding ASA – Terms of the rights issue and related transactions
May 13, 2024 Press release - Non-regulatory Circio presents pre-clinical proof-of-concept data for its circVec gene therapy platform at the ASGCT 2024 meeting
April 29, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
April 25, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
April 17, 2024 Press release - Regulatory Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus
April 17, 2024 Press release - Regulatory Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025
April 17, 2024 Press release - Regulatory Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment
April 9, 2024 Press release - Non-regulatory Circio invites to a company update on Wednesday 17 April 2024
March 27, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
March 21, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
March 19, 2024 Press release - Regulatory Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China
March 13, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
March 5, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
March 4, 2024 Press release - Non-regulatory The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities
March 4, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
February 27, 2024 Press release - Non-regulatory Circio to participate in the Annual European Life Sciences CEO Forum in Zürich
February 7, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
February 5, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
February 1, 2024 Press release - Non-regulatory The first patient has been dosed in Circio’s TG01 triple combination study
January 18, 2024 Press release - Regulatory Circio receives waiver of EUR 6.2 million in loans from Business Finland
January 12, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
January 10, 2024 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
January 4, 2024 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
